Results 111 to 120 of about 50,974 (272)
Clinics, 2018 OBJECTIVES: Patients receiving treatment for tuberculosis are at risk of developing acute liver failure due to the hepatotoxicity of antitubercular drugs.
Rodrigo Bronze de Martino +4 more
doaj +1 more source
Phenothiazines as a solution for multidrug resistant tuberculosis: From the origin to present [PDF]
, 2015 Historically, multiplicity of actions in synthetic compounds is a rule rather than exception. The science of non-antibiotics evolved in this background.
Debalina Sinha Roy +6 more
core +1 more source
FEBS Letters, 2019 Tuberculosis (TB) is a leading killer caused by Mycobacterium tuberculosis. Recently, anti‐TB peptides have provided an alternative approach to combat antibiotic tolerance.
Shamima Khatun, M. Hasan, H. Kurata
semanticscholar +1 more source
Osteoarticular Tuberculosis: a Secondary Manifestations to Tuberculous Pleural Effusion [PDF]
, 2014 Tuberculosis appears to be increasing throughout the world after years of continuous decline, despite the introduction of effective chemotherapy. This resurgence is related to the increasing number of patients immunocompromised by chemotherapeutic agents
Rumende, C. M. (Cleopas) +2 more
core
_M. tuberculosis_ interactome analysis unravels potential pathways to drug resistance [PDF]
, 2008 Drug resistance is a major problem for combating tuberculosis. Lack of understanding of how resistance emerges in bacteria upon drug treatment limits our ability to counter resistance.
Karthik Raman, Nagasuma Chandra
core +1 more source
BMC Infectious Diseases, 2019 Background Multidrug-resistant tuberculosis (MDR-TB) requires lengthy use of second-line drugs, burdened by many side effects. Hepatitis C virus (HCV) chronic infection increases risk of drug-induced liver injury (DILI) in these patients.
Maria Musso +9 more
doaj +1 more source
Design, synthesis, antitubercular and antiviral properties of new spirocyclic indole derivatives
Chemical Monthly, 2019 A series of indole-based spirothiazolidinones have been designed, synthesized and evaluated, in vitro, for their antitubercular, antiviral, antibacterial, and antifungal activities.
Gökçe Cihan-Üstündağ +5 more
semanticscholar +1 more source
Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
Case Reports in Gastroenterology, 2011 Pseudomembranous colitis (PMC) may develop with long-term antibiotic administration, but is rarely reported to be caused by antitubercular agents. We present a case of PMC that occurred 120 days after starting rifampicin.
Jeong Moon Choi +4 more
doaj +1 more source
A real‐world experience with 6 months of antitubercular therapy in abdominal tuberculosis
JGH Open, 2019 Abdominal tuberculosis is an important form of extrapulmonary tuberculosis. Evidence from clinical trials suggests that 6 months of antitubercular therapy (ATT) is sufficient for abdominal tuberculosis.
H. Mandavdhare +3 more
semanticscholar +1 more source
Experimental pharmacological research regarding some new quinazolin-4-ones derivatives [PDF]
, 2019 A series of new compounds with quinazolin-4-one structure, synthesized by the Pharmaceutical Chemistry Department of the Faculty of Pharmacy of the University of Medicine and Pharmacy “Carol Davila” Bucharest, was studied.
Bratu, Mihaela +8 more
core +1 more source